A man who discovered he had prostate cancer following a free blood test run by a volunteer group has urged other men to get ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

“This test could turn the tide on prostate cancer,” said Prof. Ros Eeles, who led the study. “We have shown that a relatively ...

Study findings provide valuable clinical information for metastatic castration-sensitive prostate cancer (mCSPC) prognosis in routine clinical practice.

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

YearDelivers Improved Gross Margins, Achieves Annual Cost Savings Target Early, and Reduces Cash Burn Over 55% IRVINE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- ...

Revenue and Sales Performance: For the fiscal third quarter of 2025, Biomerica reported net sales of $1.10 million, a 10% increase from $1.00 million recorded in the same quarter of the previous year.

The White House released the results of President Trump’s annual physical examination on Sunday.

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

The saliva test appears to be more accurate than the standard test, which uses blood samples. View on euronews ...

The prostate-specific antigen (PSA) test is a blood test which is used to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not currently ...